| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.922 | 47.901 | 46.896 | 61.668 | 58.548 | 44.169 | 55.015 | 54.685 | 55.061 | 4.602 |
| Total Income - EUR | 49.000 | 47.933 | 46.978 | 61.683 | 58.563 | 44.306 | 56.340 | 55.788 | 56.644 | 4.655 |
| Total Expenses - EUR | 21.370 | 18.509 | 21.797 | 33.441 | 35.818 | 28.283 | 34.683 | 31.423 | 32.320 | 6.850 |
| Gross Profit/Loss - EUR | 27.630 | 29.424 | 25.181 | 28.242 | 22.746 | 16.023 | 21.657 | 24.365 | 24.324 | -2.196 |
| Net Profit/Loss - EUR | 26.160 | 27.986 | 23.760 | 27.625 | 22.160 | 15.615 | 21.094 | 23.835 | 23.757 | -2.196 |
| Employees | 2 | 1 | 1 | 3 | 3 | 3 | 3 | 2 | 2 | 0 |
Check the financial reports for the company - Oftamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.989 | 4.673 | 1.038 | 700 | 373 | 87 | 0 | 0 | 0 | 0 |
| Current Assets | 20.473 | 23.482 | 22.951 | 51.001 | 24.442 | 16.175 | 21.555 | 24.423 | 25.205 | 3.254 |
| Inventories | 1.065 | 796 | 1.399 | 1.747 | 2.331 | 2.845 | 420 | 563 | 1.917 | 1.910 |
| Receivables | 57 | 7 | 4 | 54 | 52 | 63 | 62 | 62 | 71 | 71 |
| Cash | 19.351 | 22.679 | 21.548 | 49.201 | 22.059 | 13.267 | 21.073 | 23.798 | 23.217 | 1.273 |
| Shareholders Funds | 26.234 | 28.059 | 23.831 | 51.018 | 22.229 | 15.682 | 21.213 | 23.954 | 23.986 | -1.969 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 228 | 96 | 158 | 682 | 2.586 | 580 | 342 | 469 | 1.219 | 5.222 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftamed Srl